Comparison between the Hybrid Capture II test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples

Journal of Clinical Microbiology

Volumn 44, Issue 5, 2006, Pages 1733-1739

  Huang, Shang Lang ^a   Chao, Angel ^a,b   Hsueh, Swei ^a   Chao, Fang Yu ^a   Huang, Chu Chun ^a   Yang, Jung Erh ^a   Lin, Ching Yu ^c   Yan, Chiu Cho ^c   Chou, Hung Hsueh ^a   Huang, Kuan Gen ^a   Huang, Huei Jean ^a   Wu, Tzu I ^a   Tseng, Mao Jung ^a   Qiu, Jian Tai ^a   Lin, Cheng Tao ^a   Chang, Ting Chang ^a   Lai, Chyong Huey ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c King Car Food Industrial Co Ltd   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE; COLPOSCOPY; CONTROLLED STUDY; DEVICE; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL; SQUAMOUS CELL METAPLASIA; STATISTICAL ANALYSIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

BASE SEQUENCE; CERVIX UTERI; DNA PRIMERS; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; VAGINAL SMEARS;

HUMAN PAPILLOMAVIRUS;

EID: 33646543308     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.5.1733-1739.2006     Document Type: Article

References (30)

1. Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. 2000. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J. Natl. Cancer Inst. 92:397-402.
2. Baay, M. F., W. G. Quint, J. Koudstaal, H. Hollema, J. M. Duk, M. P. Burger, E. Stolz, and P. Herbrink. 1996. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J. Clin. Microbiol. 34:745-747.
3. Campion, M. J., D. J. McCance, J. Cuzick, and A. Singer. 1986. Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet ii:237-240.
4. Chao, A., C. T. Lin, S. Hsueh, H. H. Chou, T. C. Chang, M. Y. Chen, and C. H. Lai. 2004. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization. Am. J. Obstet. Gynecol. 190:1046-1051.
5. Coutlee, F., P. Gravitt, H. Richardson, C. Hankins, E. Franco, N. Lapointe, H. Voyer, and the Canadian Women's HIV Study Group. 1999. Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay. J. Clin. Microbiol. 37:1852-1857.
6. de Roda Husman, A. M., J. M. Walboomers, A. J. van den Brule, C. J. Meijer, and P. J. Snijders. 1995. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76:1057-1062.
7. Gravitt, P. E., C. L. Peyton, R. J. Apple, and C. M. Wheeler. 1998. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol. 36:3020-3027.
8. Herrington, C. S., M. F. Evans, F. M. Charnock, W. Gray, and J. O'D McGee. 1996. HPV testing in patients with low grade cervical cytological abnormalities: a follow up study. J. Clin. Pathol. 49:493-496.
9. Hildesheim, A., M. H. Schiffman, P. E. Gravitt, A. G. Glass, C. E. Greer, T. Zhang, D. R. Scott, B. B. Rush, P. Lawler, M. E. Sherman, R. J. Kurman, and M. M. Manos. 1994. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 169:235-240.
10. Ho, G. Y., R. D. Burk, S. Klein, A. S. Kadish, C. J. Chang, P. Palan, J. Basu, R. Tachezy, R. Lewis, and S. Romney. 1995. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. Natl. Cancer Inst. 87:1365-1371.
11. Huang, H. J., S. L. Huang, C. Y. Lin, R. W. Lin, F. Y. Chao, M. Y. Chen, T. C. Chang, S. Hsueh, K. H. Hsu, and C. H. Lai. 2004. Human papillomavirus genotyping by a polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery. Int. J. Gynecol. Cancer 14:639-649.
12. Huang, S., I. Afonina, B. A. Miller, and A. M. Beckmann. 1997. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int. J. Cancer 70:408-411.
13. Kleter, B., L. J. van Doorn, L. Schrauwen, A. Molijn, S. Sastrowijoto, J. ter Schegget, J. Lindeman, B. ter Harmsel, M. Burger, and W. Quint. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:2508-2517.
14. Koutsky, L. A., K. K. Holmes, C. W. Critchlow, C. E. Stevens, J. Paavonen, A. M. Beckmann, T. A. DeRouen, D. A. Galloway, D. Vernon, and N. B. Kiviat. 1992. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med. 327:1272-1278.
15. Kulasingam, S. L., J. P. Hughes, N. B. Kiviat, C. Mao, N. S. Weiss, J. M. Kuypers, and L. A. Koutsky. 2002. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 288:1749-1757.
16. Lin, C. T., C. J. Tseng, C. H. Lai, S. Hsueh, K. G. Huang, H. J. Huang, and A. Chao. 2001. Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen. Am. J. Obstet. Gynecol. 184:940-945.
17. Low, S. H., T. W. Thong, T. H. Ho, Y. S. Lee, T. Monta, M. Singh, E. H. Yap, and Y. C. Chan. 1990. Prevalence of human papillomavirus types 16 and 18 in cervical carcinomas: a study by dot and Southern blot hybridization and the polymerase chain reaction. Jpn. J. Cancer Res. 81:1118-1123.
18. Manos, M. M., W. K. Kinney, L. B. Hurley, M. E. Sherman, J. Shieh-Ngai, R. J. Kurman, J. E. Ransley, B. J. Fetterman, J. S. Hartinger, K. M. McIntosh, G. F. Pawlick, and R. A. Hiatt. 1999. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 281:1605-1610.
19. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
20. Pao, C. C., S. S. Lin, C. Y. Lin, J. S. Maa, C. H. Lai, and T. T. Hsieh. 1991. Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells. Am. J. Clin. Pathol. 95:540-546.
21. Peyton, C. L., M. Schiffman, A. T. Lorincz, W. C. Hunt, I. Mielzynska, C. Bratti, S. Eaton, A. Hildesheim, L. A. Morera, A. C. Rodriguez, R. Herrero, M. E. Sherman, and C. M. Wheeler. 1998. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J. Clin. Microbiol. 36:3248-3254.
22. Poljak, M., I. J. Marin, K. Seme, and A. Vince. 2002. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J. Clin. Virol. 25:589-97.
23. Quint, W. G., S. R. Pagliusi, N. Lelie, E. M. de Villiers, C. M. Wheeler, and the World Health Organization Human Papillomavirus DNA International Collaborative Study Group. 2006. Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA. J. Clin. Microbiol. 44:571-579.
24. Schiffman, M. H., H. M. Bauer, R. N. Hoover, A. G. Glass, D. M. Cadell, B. B. Rush, D. R. Scott, M. E. Sherman, R. J. Kurman, S. Wacholder, C. K. Stanton, and M. M. Manos. 1993. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:958-964.
25. Sherman, M. E., M. H. Schiffman, A. T. Lorincz, M. M. Manos, D. R. Scott, R. J. Kuman, N. B. Kiviat, M. Stoler, A. G. Glass, and B. B. Rush. 1994. Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am. J. Clin. Pathol. 102:182-187.
26. Solomon, D., M. Schiffman, and R. Tarone. 2001. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J. Natl. Cancer Inst. 93:293-299.
27. 10 line probe assay. J. Clin. Microbiol. 40:979-983.
28. van Muyden, R. C., B. W. ter Harmsel, F. M. Smedts, J. Hermans, J. C. Kuijpers, N. T. Raikhlin, S. Petrov, A. Lebedev, F. C. Ramaekers, J. B. Trimbos, B. Kleter, and W. G. Quint. 1999. Detection and typing of human papillomavirus in cervical carcinomas in Russian women: a prognostic study. Cancer 85:2011-2016.
29. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
30. zur Hausen, H. 1996. Papillomavirus infections-a major cause of human cancers. Biochim. Biophys. Acta 1288:F55-F78.